TERA FOUST: Open Payments
NPI 1346002615 · TITUSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| DePuy Synthes Sales Inc. | 1 | $118 |
| Gilead Sciences, Inc. | 1 | $111 |
| ABBVIE INC. | 5 | $96 |
| Phathom Pharmaceuticals, Inc. | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Intercept Pharmaceuticals, Inc. | 1 | $29 |
| TOLMAR, INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
| Becton, Dickinson and Company | 1 | $16 |
Products named: VOQUEZNA, RINVOQ, ENTYVIO, OCALIVA, JATENZO, Ozempic, MAVYRET, LINZESS.
Industry payments across FL — which companies pay providers there.
